ArticleBMJ public health2026
Factors associated with tuberculosis symptom reporting among persons deprived of liberty in Brazil during active case finding: a cross-sectional study.
Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comment on: Precision geospatial targeting for cost-effective tuberculosis case finding in Eastern Uganda: A quasi-experimental study.Therapeutic advances in infectious diseaseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Active case finding (ACF) can improve tuberculosis (TB) diagnosis in high-burden populations. Many programmes rely on symptom evaluation as the first screening step; however, symptom reporting may vary according to the context of evaluation. Methods: We performed a cross-sectional analysis of persons deprived of liberty (PDL) diagnosed with TB in an ACF programme conducted in two male Brazilian prisons from February 2023 to February 2025. Every 4 months, participants underwent sputum testing by GeneXpert Ultra (Xpert) and culture. Study nurses administered symptom questionnaires during the initial evaluation. Individuals with positive results were interviewed by a physician. We compared characteristics of individuals with microbiologically confirmed TB according to their symptom reporting at initial screening and medical consultation, which was used to define four groups (e.g., combinations of symptomatic/asymptomatic at each of the two symptom assessments). Results: Among 6919 PDL screened, 448 (6.4%) had microbiologically confirmed TB. We included 292 (65.1%) individuals in the analysis, after excluding those with missing clinical information and consults >15 days after screening. 113 (38.7%) reported symptoms at initial screening, while 192 (65.8%) reported symptoms at medical consultation (p<0.001). Compared with individuals asymptomatic at both evaluations, those who reported symptoms at the two instances were more likely to have medium or high semiquantitative Xpert results (45.0% vs 11.4%, p<0.001), report symptomatic cellmates (61.0% vs 25.2%, p<0.001), have higher LunitTB scores (95.1 vs 91.9; p=0.037) and lower body mass index (19.4 vs 21.4, p<0.001). There was a trend of more cavitary lesions (60.9% vs 50.0%, p=0.073) and bilateral disease (56.7% vs 45.0%, p=0.056) in chest X-ray of participants with symptomatic than asymptomatic TB at medical consultation. Conclusions: More than half of individuals who reported no TB symptoms at initial screening endorsed symptoms at first medical consultation. Clinical severity and contextual factors can influence TB symptom reporting during ACF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.